Home - Products - Tyrosine Kinase - CSF1R - c-Fms-IN-13

c-Fms-IN-13

CAS No. 885704-58-5

c-Fms-IN-13( —— )

Catalog No. M35575 CAS No. 885704-58-5

c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (IC50 = 17 nM) and serves as an anti-inflammatory agent.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	28	In Stock
10MG	28	In Stock
25MG	54	In Stock
50MG	77	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

c-Fms-IN-13
Note

Research use only, not for human use.
Brief Description

c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (IC50 = 17 nM) and serves as an anti-inflammatory agent.
Description

c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor with an IC50 value of 17 nM. c-Fms-IN-13 can be used as an anti-inflammatory agent.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Tyrosine Kinase
Target

CSF1R
Recptor

c-Fms
Research Area

——
Indication

——

Chemical Information

CAS Number

885704-58-5
Formula Weight

378.47
Molecular Formula

C22H26N4O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 31.25 mg/mL (82.57 mM; Ultrasonic )
SMILES

O=C(Nc1ccc(cc1N1CCCCC1)N1CCCCC1)c1ccc(o1)C#N
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Illig CR, et al. Discovery of novel FMS kinase inhibitors as anti-inflammatory agents. Bioorg Med Chem Lett. 2008 Mar 1;18(5):1642-8.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Axatilimab

Axatilimab (SNDX-6352) is a human IgG4 antibody targeting the colony-stimulating factor 1 receptor (CSF-1R), which can be used for the study of immune system disorders and respiratory diseases.
Gimsilumab

Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
Anumigilimab

Anumigilimab (CSL-324) is a fully human therapeutic anti-G-CSFR antibody with potential anti-tumor activity for the study of inflammation.

Sign In Join Free